Skip to main content

Table 2 Changes in lipid profile during treatment according to treatment group1(paired sample t teatst)

From: Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting

 

Group A

Group B

Group C

Number of patients2

32

55

28

Initial triglycerides (mg/dl, +/- SD)

170 ± 53

184 ± 49

255 ± 205

Final triglycerides (mg/dl, +/- SD)

139 ± 43

153 ± 35

165 ± 60

Delta (+/- SD)

-31 ± 21

-31 ± 25

-90 ± 187

P value (pre-post)

<0.001

<0.001

0.01

Initial low density lipids (LDL; mg/dl, +/- SD)

150 ± 30

156 ± 36

152 ± 44

Final LDL (mg/dl, +/- SD)

129 ± 28

143 ± 32

147 ± 34

Delta

-21 ± 26

-12 ± 16

-5 ± 34

P value (pre-post)

<0.001

<0.001

NS

Initial high density lipids (HDL; mg/dl, +/- SD)

42 ± 7.0

44 ± 6.7

47 ± 14.9

Final HDL (mg/dl, +/- SD)

43 ± 6.6

45 ± 6.7

48 ± 15.3

Delta (+/- SD)

0.9 ± 2.9

0.8 ± 3.3

1.4 ± 8.8

P value (pre-post)

NS

NS

NS

  1. NS = Not significant.
  2. 1 See footnotes to Table 1
  3. 2 Patients with pre and post lipid profile analyses